Narrow‐band ultraviolet therapy in early‐stage mycosis fungoides: study on 20 patients
- 1 November 2007
- journal article
- clinical trial
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 23 (6) , 229-233
Abstract
Background: In recent years, narrow‐band ultraviolet B (NB‐UVB, 311–313 nm) has been found to be beneficial for early‐stages mycosis fungoides (MF). The aim of this study is to investigate the effect of NB‐UVB in 20 patients with early‐stage MF.Methods: Twenty patients (10 women and 10 men, mean age 54 ± 22 years) with clinically and histologically confirmed MF were enrolled in the study. All of the patients had clinical stage I disease (T1 or T2, N0, M0) with cutaneous involvement, consisting of patch‐stage disease of limited extent, in 50% of the cases (stage IA), and more widespread in the other 50% (stage IB). All the patients were treated with NB‐UVB therapy until more than 95% clearance of the patient's skin lesions had occurred.Results: A complete response was achieved in 90% of the cases after a mean of 29 ± 14 treatments within a mean period of 4 months (range 1–8 months), with an average cumulative dose of 25 ± 16.77 J/cm2. In the follow‐up period, relapse occurred after a mean period of 8 months (range 3–17 months), and then therapy was restarted.Conclusion: This study provides evidence that NB‐UVB might be an efficient option for stage IA and IB MF patients.Keywords
This publication has 18 references indexed in Scilit:
- UVB in the management of early stage mycosis fungoidesJournal of the European Academy of Dermatology and Venereology, 2006
- Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up dataBritish Journal of Dermatology, 2006
- Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoidesJournal of the American Academy of Dermatology, 2005
- The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up dataBritish Journal of Dermatology, 2005
- Narrowband UVB phototherapy in skin conditions beyond psoriasisJournal of the American Academy of Dermatology, 2005
- No Evidence for Increased Skin Cancer Risk in Psoriasis Patients Treated with Broadband or Narrowband UVB Phototherapy: A First Retrospective StudyActa Dermato-Venereologica, 2004
- Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: A retrospective studyJournal of the American Academy of Dermatology, 2003
- Narrowband UVB phototherapy for early-stage mycosis fungoidesJournal of the American Academy of Dermatology, 2002
- Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-upJournal of the American Academy of Dermatology, 1995
- Photocarcinogenicity of psoralens used in PUVA treatment: Present status in mouse and manJournal of Photochemistry and Photobiology B: Biology, 1990